GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Argent Biopharma Ltd (ASX:RGT) » Definitions » Momentum Rank

Argent Biopharma (ASX:RGT) Momentum Rank : 1 (As of Jun. 04, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Argent Biopharma Momentum Rank?

Argent Biopharma has the Momentum Rank of 1.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Competitive Comparison of Argent Biopharma's Momentum Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Argent Biopharma's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Argent Biopharma's Momentum Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Argent Biopharma's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Argent Biopharma's Momentum Rank falls into.



Argent Biopharma Momentum Rank Related Terms

Thank you for viewing the detailed overview of Argent Biopharma's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Argent Biopharma (ASX:RGT) Business Description

Traded in Other Exchanges
Address
295 Rokeby Road, Suite 1, Subiaco, WA, AUS, 6008
MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted global markets.

Argent Biopharma (ASX:RGT) Headlines

From GuruFocus

Royce Global Value Trust (NYSE: RGT) as of Jan 31, 2022

By PRNewswire PRNewswire 02-23-2022

Royce Global Value Trust (NYSE: RGT) as of Nov 30, 2022

By PRNewswire PRNewswire 12-29-2022

Royce Global Value Trust (NYSE: RGT) as of Oct 31, 2022

By PRNewswire PRNewswire 11-30-2022

Royce Global Value Trust (NYSE: RGT) as of Mar 31, 2023

By PRNewswire PRNewswire 04-26-2023

Royce Global Value Trust (NYSE: RGT) as of Jul 31, 2022

By PRNewswire PRNewswire 08-31-2022

Royce Global Value Trust (NYSE: RGT) as of Jan 31, 2023

By PRNewswire PRNewswire 02-27-2023

Royce Global Value Trust (NYSE: RGT) as of Apr 30, 2022

By PRNewswire PRNewswire 06-13-2022

Royce Global Value Trust (NYSE: RGT) as of Dec 31, 2021

By PRNewswire PRNewswire 01-31-2022